JPRN-jRCT1080223923已完成Unknown
Specified Drug-Use Survey of Trelagliptin Tablets Survey on long-term use in patients with type 2 diabetes mellitus
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 3,198
研究概览
简要总结
o new safety or efficacy concerns were observed with the long-term treatment with this drug of participants with type 2 diabetes mellitus.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Type 2 diabetes mellitus patients
排除标准
- •1. Have severe ketosis, diabetic coma or precoma, or type 1 diabetes mellitus
- •2. Have severe infection, perioperative status, or serious trauma
- •3. Have severe renal impairment or on dialysis due to end-stage renal disease
- •4. Have a history of hypersensitivity to any ingredients of this drug
研究者
相似试验
已完成
不适用
Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus"Type 2 Diabetes MellitusNCT03555591Takeda3,198
已完成
不适用
Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease"Type 2 Diabetes MellitusNCT04285983Takeda89
已完成
不适用
Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"Type 2 Diabetes Mellitus Who Have Been Examined at a Medical InstitutionNCT01945216Takeda3,317
已完成
不适用
Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes MellitusType 2 Diabetes MellitusNCT01964963Takeda19,192
已完成
不适用
Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"Type 2 Diabetes MellitusNCT02221284Takeda964